Interstitial pneumonitis secondary to intravesical Bacillus Calmette-Guerin for carcinoma in-situ of the bladder

International Braz J Urol

Volumn 30, Issue 5, 2004, Pages 400-402

  Diner, Eric K ^a   Verghese, Mohan ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

BCG; Bladder neoplasms; Intravesical injection; Pneumonitis

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; CORTICOSTEROID; ETHAMBUTOL; ISONIAZID; PREDNISONE; RIFAMPICIN; STEROID; THERACYS; TUBERCULOSTATIC AGENT;

AGED; ARTICLE; BLADDER CARCINOMA; CARCINOMA IN SITU; CASE REPORT; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG RESPONSE; DRUG TOLERABILITY; HOSPITAL DISCHARGE; HUMAN; INTERSTITIAL PNEUMONIA; MAINTENANCE THERAPY; MALE; PATIENT CARE; STANDARD; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 9244220685     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382004000500008     Document Type: Article

References (3)

1. Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al.: Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol. 1992; 147: 596-600.
2. Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, et al.: Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1, and carcinoma in-situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study. J. Urol. 2000; 163: 1124-9.
3. Molina J, Rabian C, D'Agay M, Modai J: Hypersensitivity systemic reaction following i intravesical bacillus Calmette-Guerin: successful treatment with steroids. J. Urol. 1992; 147: 695-7.